Glenn Alfons Friedrich
Direttore operativo presso Kymab Ltd.
Profilo
Glenn Alfons Friedrich is the founder of Ceros Pharmaceuticals, Inc. (founded in 2000).
He is currently the Director at Wrnch, Inc. and the Chief Operating Officer at Kymab Ltd.
(since 2014).
Previously, he worked as a Senior Research Director at BCM Technologies, Inc. (2005-2007), a Senior Scientist at Lexicon Pharmaceuticals, Inc., and a Principal at Progression Therapeutics, Inc. Dr. Friedrich completed his undergraduate degree at the University of Alberta and holds a doctorate from Baylor College of Medicine.
Posizioni attive di Glenn Alfons Friedrich
Società | Posizione | Inizio |
---|---|---|
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Direttore operativo | - |
Wrnch, Inc.
Wrnch, Inc. Packaged SoftwareTechnology Services Wrnch, Inc. operates as computer vision Software Company. It is an automated human motion capture system that takes 2D video and outputs 3D skeletonal animation data. The company was founded by Paul Kruszewski and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Glenn Alfons Friedrich
Società | Posizione | Fine |
---|---|---|
BCM Technologies, Inc.
BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Direttore della Ricerca - Azioni | 01/01/2007 |
LEXICON PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Progression Therapeutics, Inc.
Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | - |
Ceros Pharmaceuticals, Inc.
Ceros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceros Pharmaceuticals, Inc. develops compounds to treat osteoporosis. The company is based in Houston, TX. The company was founded by Glenn Alfons Friedrich. Ceros Pharmaceuticals was acquired by Auxeris Therapeutics, Inc. on January 14, 2004. | Fondatore | - |
Formazione di Glenn Alfons Friedrich
University of Alberta | Undergraduate Degree |
Baylor College of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 5 |
---|---|
BCM Technologies, Inc.
BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Finance |
Ceros Pharmaceuticals, Inc.
Ceros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceros Pharmaceuticals, Inc. develops compounds to treat osteoporosis. The company is based in Houston, TX. The company was founded by Glenn Alfons Friedrich. Ceros Pharmaceuticals was acquired by Auxeris Therapeutics, Inc. on January 14, 2004. | Health Technology |
Progression Therapeutics, Inc.
Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Health Technology |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Wrnch, Inc.
Wrnch, Inc. Packaged SoftwareTechnology Services Wrnch, Inc. operates as computer vision Software Company. It is an automated human motion capture system that takes 2D video and outputs 3D skeletonal animation data. The company was founded by Paul Kruszewski and is headquartered in Montreal, Canada. | Technology Services |
- Borsa valori
- Insiders
- Glenn Alfons Friedrich